Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
DHS Funding Fight Threatens Medicare Services
Tech & Innovation DHS Funding Fight Threatens Medicare Services

A high-stakes legislative confrontation over the Department of Homeland Security's budget is pushing the federal government to the brink of a partial shutdown, with the nation's healthcare system caught in the crossfire as critical Medicare services hang in the balance. The standoff, rooted in a

AI Predicts Fall Risk Using Routine Abdominal Scans
Tech & Innovation AI Predicts Fall Risk Using Routine Abdominal Scans

Today we're joined by Ivan Kairatov, a biopharma expert with a deep understanding of technology and innovation in healthcare. We'll be exploring a groundbreaking study that uses artificial intelligence to analyze routine abdominal CT scans, uncovering a surprising new way to predict a person's risk

Photon-Counting CT Reduces Dose, Preserves Image Quality
Tech & Innovation Photon-Counting CT Reduces Dose, Preserves Image Quality

A foundational challenge within medical imaging has long been the delicate balance between capturing high-resolution diagnostic images and minimizing the patient's exposure to ionizing radiation. This trade-off is particularly pronounced in fields like pediatric and cardiac radiology, where

Could PIVKA-II Revolutionize HCC Management?
Tech & Innovation Could PIVKA-II Revolutionize HCC Management?

Emerging from the complexities of cancer biology, a formidable biomarker known as Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) is steadily reshaping the clinical landscape for hepatocellular carcinoma. This abnormal protein, once viewed as a simple serological anomaly resulting

What Drives the $5 Billion Fluoroscopy Device Market?
Tech & Innovation What Drives the $5 Billion Fluoroscopy Device Market?

The ability to peer inside the human body in real-time, observing the dynamic motion of organs and guiding surgical instruments with unparalleled precision, has transformed from a futuristic concept into a daily clinical reality. This capability is the domain of fluoroscopy, an imaging technique

US Exit Creates Crisis at World Health Organization
Biotech & Bioprocessing US Exit Creates Crisis at World Health Organization

The once-unbreakable bond between the United States and the World Health Organization has officially been severed, sending shockwaves through the global public health infrastructure and raising urgent questions about the future of international cooperation in an era of resurgent nationalism. This

Could This 3D Dataset Transform Emergency Medicine?
Tech & Innovation Could This 3D Dataset Transform Emergency Medicine?

The chaotic, high-stakes environment of an emergency room, where split-second decisions and precise physical actions determine patient outcomes, has long represented one of the final frontiers for advanced artificial intelligence and robotics. For these technologies to learn and assist, they must

$19M Funds Digital Twins to Defend US Hospitals
Tech & Innovation $19M Funds Digital Twins to Defend US Hospitals

The intricate web of interconnected medical devices and patient data systems that forms the backbone of modern healthcare is also its greatest vulnerability, creating a vast attack surface for cybercriminals. The healthcare sector has become a prime target, where a single breach can disrupt

Large Study Finds No Stomach Cancer Risk From PPIs
Research & Development Large Study Finds No Stomach Cancer Risk From PPIs

For millions of people who rely on proton pump inhibitors (PPIs) to manage chronic acid reflux and other gastrointestinal conditions, a persistent concern has long cast a shadow over their treatment: the potential risk of developing stomach cancer. This decades-old question has fueled anxiety among

UTSW Debuts Liver Chemo Bath for Rare Eye Cancer
Research & Development UTSW Debuts Liver Chemo Bath for Rare Eye Cancer

Today we're speaking with Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping modern medicine. We'll be delving into a remarkable breakthrough in oncology: a new, highly targeted procedure for treating metastatic uveal melanoma, a rare and aggressive eye

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later